MedPath

Tdap Vaccination for Infant Caregivers

Completed
Conditions
Pertussis
Vaccination
Interventions
Other: Survey
Registration Number
NCT01233401
Lead Sponsor
Yale University
Brief Summary

This study evaluates whether offering Tetanus, diphteria and acellular pertussis (Tdap) vaccine to caregivers of newborn infants during pediatric well child visits increase the caregivers' vaccination rates.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
102
Inclusion Criteria
  • 18-64 years old
  • English or Spanish speaking
Read More
Exclusion Criteria
  • Do not speak English or Spanish
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
MothersSurvey-
Other Infant CaregiversSurveyIncludes fathers, grandparents, and other adults who are infant caregivers
Primary Outcome Measures
NameTimeMethod
Maternal Tdap Vaccination RateAt 2 week well child visit
Secondary Outcome Measures
NameTimeMethod
Other Infant Caregiver Tdap Vaccination RateAt 2 week well child visit

Trial Locations

Locations (1)

Hospital of St. Raphael

🇺🇸

New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath